The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015.
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $32.34 to $33.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a securi
ty holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever KYTHERA Biopharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
KYTHERA Biopharmaceuticals's Chief Commercial Officer just declared ownership of no shares of KYTHERA Biopharmaceuticals - Jan. 30, 2015
KYTHERA Biopharmaceuticals's Chief Financial Officer just disposed of 25,416 shares - Jan. 27, 2015
KYTHERA Biopharmaceuticals director just disposed of 250 shares - Jan. 21, 2015
KYTHERA Biopharmaceuticals's President & CEO just picked up 28,643 shares - Jan. 8, 2015
KYTHERA Biopharmaceuticals's Chief Financial Officer just picked up 6,216 shares - Jan. 6, 2015